Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 22, 4 Issues, 2022
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 17 - Number 3






Review Article


Research Article

Atrial Fibrillation Ablation Increases Inflammation-Chemokine Modulation Suppresses Activation of Leukocytes Isolated after Ablation

, 17(3): 195 - 204

Mohammad Al-Ani, Sriram Ambadapadi, Jordan R. Yaron, Donghang Zheng, Adisson Fortunel, Maia Doroton-Guevara, Liying Liu, Sufi Morshed, Jay Fricker, William Miles, Matthew McKillop and Alexandra Lucas*


DOI: 10.2174/1871529X17666170918140442



Research Article

Previous use of Statins and Atrial Electrical Remodeling in Patients with Cryptogenic Stroke

, 17(3): 212 - 215

Maurizio Acampa*, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Andrea Lo Monaco and Giuseppe Martini


DOI: 10.2174/1871529X18666180111115646




Editor-in-Chief

Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog